文献速递间质性肺疾病

特发性肺纤维化患者步速变化与不良结局的前瞻性队列研究

Change in gait speed and adverse outcomes in patients with idiopathic pulmonary fibrosis: A prospective cohort study.
PubMed 文献 · Respirology · 2023-03-23

本研究纳入132例新诊断特发性肺纤维化(IPF)患者,测量6个月内四米步速(4MGS)变化,以死亡/首次住院为复合终点。结果显示4MGS平均下降0.05 m/s,下降≥0.07 m/s者住院/死亡风险显著增加(校正HR 4.61),提示4MGS变化可作为替代终点。

要点

  • 新诊断IPF患者6个月内4MGS平均下降0.05 m/s。
  • 4MGS下降≥0.07 m/s与6个月内住院/死亡风险增加独立相关。
  • 4MGS变化对不良结局的区分能力优于6分钟步行距离、FVC等指标。

核心结论

  • 新诊断IPF患者6个月内4MGS大幅下降与6个月内住院/死亡时间缩短相关。
  • 4MGS变化有潜力作为旨在改变住院/死亡结局的干预措施的替代终点。

研究设计与样本

  • 前瞻性队列研究,招募132例新诊断IPF患者,测量6个月内4MGS变化。
  • 85例有完整配对4MGS及索引事件数据,缺失4MGS数据采用多重插补处理。
  • 采用ROC曲线确定4MGS变化切点,Cox比例风险回归评估4MGS变化与事件时间的关系。

主要发现

  • 6个月内4MGS下降,平均变化(95%CI)为-0.05(-0.09至-0.01)m/s,p=0.02。
  • 6个月内4MGS下降≥0.07 m/s对索引事件的区分能力优于6分钟步行距离、用力肺活量、复合生理指数或性别年龄生理指数变化。
  • Kaplan-Meier曲线显示4MGS大幅下降组(>-0.07 m/s)与轻微下降/改善组(≤-0.07 m/s)事件时间差异显著,p=0.007。
  • 大幅下降组住院/死亡风险增加,校正风险比(95%CI)为4.61(1.23-15.83)。
  • 多重插补分析观察到相似结果。

关键数值与推荐

  • 4MGS变化切点:6个月内下降≥0.07 m/s定义为大幅下降。
  • 复合终点:6个月内死亡或首次住院。

临床怎么用

  • 对新建诊断IPF患者可考虑定期监测4MGS变化。
  • 6个月内4MGS下降≥0.07 m/s提示住院/死亡风险增加,需加强随访管理。

局限性

  • 完整配对4MGS及索引事件数据仅85例,缺失数据采用多重插补。
  • 研究为单队列前瞻性设计,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Gait speed is associated with survival in individuals with idiopathic pulmonary fibrosis (IPF). The extent to which four-metre gait speed (4MGS) decline predicts adverse outcome in IPF remains unclear. We aimed to examine longitudinal 4MGS change and identify a cut-point associated with adverse outcome. METHODS: In a prospective cohort study, we recruited 132 individuals newly diagnosed with IPF and measured 4MGS change over 6 months. Death/first hospitalization at 6 months were composite outcome events. Complete data (paired 4MGS plus index event) were available in 85 participants; missing 4MGS data were addressed using multiple imputation. Receiver-Operating Curve plots identified a 4MGS change cut-point. Cox proportional-hazard regression assessed the relationship between 4MGS change and time to event. RESULTS: 4MGS declined over 6 months (mean [95% CI] change: -0.05 [-0.09 to -0.01] m/s; p = 0.02). A decline of 0.07 m/s or more in 4MGS over 6 months had better discrimination for the index event than change in 6-minute walk distance, forced vital capacity, Composite Physiologic Index or Gender Age Physiology index. Kaplan-Meier curves demonstrated a significant difference in time to event between 4MGS groups (substantial decline: >-0.07 m/s versus minor decline/improvers: ≤-0.07 m/s; p = 0.007). Those with substantial decline had an increased risk of hospitalization/death (adjusted hazard ratio [95% CI] 4.61 [1.23-15.83]). Similar results were observed in multiple imputation analysis. CONCLUSION: In newly diagnosed IPF, a substantial 4MGS decline over 6 months is associated with shorter time to hospitalization/death at 6 months. 4MGS change has potential as a surrogate endpoint for interventions aimed at modifying hospitalization/death.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Nolan CM, Schofield SJ, Maddocks M, et al. Change in gait speed and adverse outcomes in patients with idiopathic pulmonary fibrosis: A prospective cohort study. Respirology. 2023. PMID: 36958946. doi:10.1111/resp.14494

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。